UK researchers set up central clinical trials unit
This article was originally published in Clinica
Executive Summary
The UK Medical Research Council has established a clinical trials unit, which will incorporate existing HIV and cancer trial centres and fund work on trial infrastructures in a number of new disease fields. Staff at the Council's London-based HIV clinical trial centre and its cancer trials office in Cambridge will relocate to become part of the new unit, which is expected to operate from a site at University College, London.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.